Marijuana is steadily becoming accepted by the general public as a recreational drug. Even pharmaceutical companies are trying to develop new ways to administer the drug for medicinal purpose. Toda, Teva Israel has announced a new agreement with Syqe Medical for the marketing of the world’s first marijuana inhaler.
Teva Israel, a subsidiary of Teva Pharmaceutical Industries will be the exclusively in charge of distributing in Israel the marijuana inhaler and its cartridges produced by Syqe Medical. The agreement also states that both companies will fund an instruction and support array for medical staff as well as patients.
A recent report reveals that in 2017, Israel had a number of 26,000 licenses for the medical use of cannabis. It also estimates this number will very likely double by the end of 2018, with the average marijuana user spends around $1,000 per year. These figures indicate that the collaboration between the two companies will prove very lucrative for both.
Until now, patients who smoked marijuana for various medicinal purposes like alleviating pain were not able to properly regulate the dosage. The new marijuana inhaler is an efficient solution to this problem by allowing patients to inhale the optimal dosage required to ease their pain.
The inhaler will also be designed for a variety of patients and their different diseases, while taking into consideration the indication of the Israeli Ministry of Health. The marijuana inhaler has already been tested regularly for half of year in the Rambam Medical Center in Haifa. This makes it the first hospital in the world to officially use marijuana for medical treatments.
The marijuana inhaler will feature biodegradable cartridges which will be marketed and distributed through Teva’s network of doctors, nurses, pain clinics and pharmacies while maintaining the company’s high pharmaceutical standards.
The inhaler is the first one of its kind as it is able to properly control the dosage of medicinal plants, thus assuring the precision and safety of a regular drug. The inhaler successfully passed several clinical trials showing that it meets the standards of the industry.
However, as useful as it may be, the marijuana inhaler is still not as cool as rolling up a joint yourself and smoking it. It remains to be seen how popular it will become in the coming months.
Image source: Wikimedia